BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/20/2024 8:03:27 AM | Browse: 58 | Download: 183
 |
Received |
|
2024-05-25 22:48 |
|
Peer-Review Started |
|
2024-05-25 22:48 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2024-06-22 16:12 |
|
Revised |
|
2024-07-12 01:24 |
|
Second Decision |
|
2024-07-22 02:43 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2024-07-23 10:28 |
|
Articles in Press |
|
2024-07-23 10:28 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-07-31 06:40 |
|
Publish the Manuscript Online |
|
2024-09-20 08:03 |
| ISSN |
2220-3230 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Transplantation |
| Manuscript Type |
Minireviews |
| Article Title |
Clinical use of donor-derived cell-free DNA in kidney transplantation
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Vishal Jaikaransingh, Bhaktidevi Makadia, Hafiz S Khan and Irtiza Hasan |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Vishal Jaikaransingh, MBBS, Assistant Professor, Department of Medicine, Divison of Nephrology, University of Florida College of Medicine-Jacksonville, 655 West 8th Street, C290, Jacksonvillie, FL 32209, United States. vishal.jaikaransingh@jax.ufl.edu |
| Key Words |
Kidney; Transplant; Donor-derived cell-free DNA; Transplant rejection; Biomarker |
| Core Tip |
Recently published data strongly supports the use of donor-derived cell-free DNA (dd-cf DNA) for routine monitoring of kidney transplants for injury and rejection. Commercial assays for dd-cf DNA have been available for more than 5 years and their use is growing however, older data supporting their use was limited to single center studies with small sample sizes. Within the last two years, newer data has emerged in larger, multi center studies and give further insight into the performance of this test and it's ability to diagnose kidney transplant rejection, predict patients at risk for rejection long before the clinical event and aid in treatment of rejection. This review aims to review the most recent literature and provide an argument for the inclusion of dd-cf DNA in the routine care of kidney transplant recipients. |
| Publish Date |
2024-09-20 08:03 |
| Citation |
<p>Jaikaransingh V, Makadia B, Khan HS, Hasan I. Clinical use of donor-derived cell-free DNA in kidney transplantation. <i>World J Transplant</i> 2024; 14(4): 97219</p> |
| URL |
https://www.wjgnet.com/2220-3230/full/v14/i4/97219.htm |
| DOI |
https://dx.doi.org/10.5500/wjt.v14.i4.97219 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
